Convection-enhanced delivery of a topoisomerase I inhibitor (nanoliposomal topotecan) and a topoisomerase II inhibitor (pegylated liposomal doxorubicin) in intracranial brain tumor xenografts

Despite multimodal treatment options, the response and survival rates for patients with malignant gliomas remain dismal. Clinical trials with convection-enhanced delivery (CED) have recently opened a new window in neuro-oncology to the direct delivery of chemotherapeutics to the CNS, circumventing t...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Yamashita, Yoji, Krauze, Michal T., Kawaguchi, Tomohiro, Noble, Charles O., Drummond, Daryl C., Park, John W., Bankiewicz, Krystof S.
Format: Artigo
Idioma:Inglês
Publicat: Duke University Press 2007
Matèries:
Basic and Translational Investigations
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC1828110/
https://ncbi.nlm.nih.gov/pubmed/17018695
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1215/15228517-2006-016
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars